Cardiol Therapeutics INC. (CRDL) SEC Filings — 2024
27 SEC filings for Cardiol Therapeutics INC. (CRDL) in 2024.
Filings
- Cardiol Therapeutics Files 6-K Report — 6-K · Nov 18, 2024
- Cardiol Therapeutics Files 6-K with Q3 Financials — 6-K · Nov 14, 2024
- Cardiol Therapeutics INC. SC 13G/A Filing — SC 13G/A · Nov 6, 2024
- Cardiol Therapeutics Files 6-K, Reports for October 2024 — 6-K · Oct 22, 2024
- Cardiol Therapeutics Closes $10M Financing — 6-K · Oct 11, 2024
- Cardiol Therapeutics Closes $13.5M Public Offering — 6-K · Oct 10, 2024
- Cardiol Therapeutics Inc. Files 6-K, Incorporates Exhibit — 6-K · Oct 9, 2024
- Cardiol Therapeutics Files 6-K, Incorporates Exhibits — 6-K · Oct 8, 2024
- Cardiol Therapeutics Files 6-K, Includes News Release — 6-K · Sep 24, 2024
- Cardiol Therapeutics Files 6-K Report — 6-K · Sep 10, 2024
- Cardiol Therapeutics Files 6-K with Financials — 6-K · Aug 12, 2024
- Cardiol Therapeutics Inc. Files 6-K, Incorporates Exhibit — 6-K · Jul 16, 2024
- Cardiol Therapeutics Files 6-K with News Release — 6-K · Jun 27, 2024
- Cardiol Therapeutics Files 6-K Report — 6-K · Jun 25, 2024
- Cardiol Therapeutics Files 6-K with News Release — 6-K · Jun 13, 2024
- Cardiol Therapeutics Files Annual Meeting Documents — 6-K · May 28, 2024
- Cardiol Therapeutics Files Q1 2024 Financial Update — 6-K · May 14, 2024
- Cardiol Therapeutics Files 6-K — 6-K · May 14, 2024
- Cardiol Therapeutics Files 6-K with Meeting Notice — 6-K · Apr 26, 2024
- Cardiol Therapeutics Files 6-K Report — 6-K · Apr 2, 2024
- Cardiol Therapeutics Inc. Files 20-F Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 1, 2024
- Cardiol Therapeutics Files 6-K, Confirms 20-F Reporting — 6-K · Feb 26, 2024
- Cardiol Therapeutics Files 6-K, Confirms 20-F Annual Reporting — 6-K · Feb 21, 2024
- Cardiol Therapeutics Files Routine 6-K for News Release — 6-K · Feb 15, 2024
- Cardiol Therapeutics INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Cardiol Therapeutics Regains Nasdaq Compliance, Averting Delisting Risk — 6-K · Jan 24, 2024
- Cardiol Therapeutics Exceeds 50% Enrollment in ARCHER Trial — 6-K · Jan 9, 2024